<p>Fiduciary Management Inc. WI 在最近向美國證券交易委員會提交的 13F 表格中表示，在第四季度將其在 Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 免費報告) 的持股比例降低了 9.1%。該公司在季度內出售了 495,419 股後，持有 4,961,969 股該公司的股票。Fiduciary Management Inc. WI 在最近一個季度末持有 Fresenius Medical Care AG &amp; Co. KGaA 約 0.86% 的股份，價值 118,194,000 美元。</p>
<ul>
<li>醫院股票 - 最佳醫院股票推薦</li>
</ul>
<p>其他幾家機構投資者最近也對 FMS 的持倉進行了調整。美國銀行公司 DE 在第二季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 279.7%。美國銀行公司 DE 目前持有 337,316 股該公司的股票，價值 9,637,000 美元，此前在此期間又購買了 248,477 股。ABC Arbitrage SA 在第四季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1,136.0%。ABC Arbitrage SA 目前持有 249,800 股該公司的股票，價值 5,950,000 美元，此前在此期間又購買了 229,589 股。Pzena Investment Management LLC 在第三季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1.0%。Pzena Investment Management LLC 目前持有 14,816,852 股該公司的股票，價值 390,128,000 美元，此前在此期間又購買了 153,870 股。Qube Research &amp; Technologies Ltd 在第二季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 175.3%。Qube Research &amp; Technologies Ltd 目前持有 199,563 股該公司的股票，價值 5,702,000 美元，此前在此期間又購買了 127,073 股。最後，Moran Wealth Management LLC 在第四季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 67.4%。Moran Wealth Management LLC 目前持有 264,462 股該公司的股票，價值 6,299,000 美元，此前在此期間又購買了 106,438 股。機構投資者目前持有該公司 8.37% 的股份。</p>
<h2>分析師設定新目標價</h2>
<p>幾位研究分析師最近對 FMS 股票發表了看法。Zacks Research 在 5 月 27 日的報告中將 Fresenius Medical Care AG &amp; Co. KGaA 的股票評級從 &#34;持有&#34; 下調至 &#34;強烈賣出&#34;。Wall Street Zen 在 5 月 9 日的報告中將 Fresenius Medical Care AG &amp; Co. KGaA 的股票評級從 &#34;買入&#34; 下調至 &#34;持有&#34;。Weiss Ratings 在 5 月 7 日的研究報告中將 Fresenius Medical Care AG &amp; Co. KGaA 的評級從 &#34;持有 (c+)&#34; 下調至 &#34;持有 (c)&#34;。花旗集團在 4 月 24 日的研究報告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;中性&#34; 評級。最後，摩根士丹利在 5 月 6 日的研究報告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;減持&#34; 評級。四位分析師對該股票給予了持有評級，五位分析師對該公司的股票給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 &#34;強烈賣出&#34;，共識目標價為 28.00 美元。</p>
<ul>
<li>最佳醫療保健股票 - 現在值得購買的醫療保健股票</li>
</ul>
<p><strong>獲取我們關於 Fresenius Medical Care AG &amp; Co. KGaA 的最新股票報告</strong></p>
<h2>Fresenius Medical Care AG &amp; Co. KGaA 股票上漲 0.4%</h2>
<p>FMS 週五開盤價為 22.03 美元。該股票的市值為 119 億美元，市盈率為 11.59，市盈率/增長比率為 3.97，貝塔值為 0.80。該公司的速動比率為 0.86，流動比率為 1.20，債務與股本比率為 0.40。Fresenius Medical Care AG &amp; Co. KGaA 的 52 周低點為 20.02 美元，52 周高點為 29.07 美元。該公司的 50 日簡單移動平均線為 22.23 美元，200 日簡單移動平均線為 22.87 美元。</p>
<p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 獲取免費報告) 最近於 3 月 31 日發佈了其財報。該公司報告季度每股收益為 1.05 美元。該業務的季度收入為 53.4 億美元。Fresenius Medical Care AG &amp; Co. KGaA 的股本回報率為 8.90%，淨利潤率為 4.88%。作為一個整體，研究分析師預計 Fresenius Medical Care AG &amp; Co. KGaA 在當前財政年度將發佈 2.24 美元的每股收益。</p>
<h2>Fresenius Medical Care AG &amp; Co. KGaA 增加股息</h2>
<p>該公司最近還宣佈了一項年度股息，將於 6 月 8 日支付。5 月 22 日的登記投資者將獲得 0.8716 美元的股息。這比 Fresenius Medical Care AG &amp; Co. KGaA 之前的年度股息 0.79 美元有所增加。這代表了 402.0% 的收益率。該股息的除息日期為 5 月 22 日。Fresenius Medical Care AG &amp; Co. KGaA 目前的派息比率為 32.11%。</p>
<h2>Fresenius Medical Care AG &amp; Co. KGaA 公司簡介</h2>
<p>(免費報告)</p>
<p>Fresenius Medical Care AG &amp; Co KGaA 是全球最大的腎臟疾病產品和服務的綜合供應商。該公司的主要業務活動包括運營透析診所以及製造和分銷透析設備、透析機、透析器、耗材和相關療法。通過其全球診所網絡，Fresenius Medical Care 提供全面的腎臟護理，包括血液透析和腹膜透析治療、患者教育和支持服務。</p>
<p>在其產品部門，該公司設計和生產透析機、水處理系統以及高通量透析器和血管通路等一次性耗材。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Samsara 剛剛回答了 AI 問題——華爾街準備好傾聽了嗎？</li>
<li>IREN 的 800MW 投資開啓了 AI 電力開關</li>
<li>CrowdStrike 財報超預期引發拋售——是否值得買入？</li>
<li>特斯拉的電動車反彈讓 Rivian 和 Lucid 面臨更嚴峻的投資者考驗</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 嗎？</h2>
<p>在考慮 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Fresenius Medical Care AG &amp; Co. KGaA 並不在名單上。</p>
<p>雖然 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析師中被評為強烈賣出，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Fiduciary Management Inc. WI 在第四季度減少了對 Fresenius Medical Care AG & Co. KGaA (FMS) 的持股，減持幅度為 9.1%，出售了 495,419 股。其他機構如美國銀行和 ABC Arbitrage 則增加了持股。分析師最近下調了 FMS 的評級，Zacks 將其評級降至 “強烈賣出”，其他機構也進行了評級調整，導致共識評級為 “強烈賣出”，目標價為 28 美元。該股票目前交易價格約為 22 美元，最近的財報顯示每股收益為 1.05 美元</p>

<p>Fiduciary Management Inc. WI lowered its position in Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,961,969 shares of the company's stock after selling 495,419 shares during the quarter. Fiduciary Management Inc. WI owned about 0.86% of Fresenius Medical Care AG &amp; Co. KGaA worth $118,194,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Fiduciary Management Inc. WI 在最近向美國證券交易委員會提交的 13F 表格中表示，在第四季度將其在 Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 免費報告) 的持股比例降低了 9.1%。該公司在季度內出售了 495,419 股後，持有 4,961,969 股該公司的股票。Fiduciary Management Inc. WI 在最近一個季度末持有 Fresenius Medical Care AG &amp; Co. KGaA 約 0.86% 的股份，價值 118,194,000 美元。</p>
</div><ul>
<li>Hospital Stocks - Best Hospital Stocks to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>醫院股票 - 最佳醫院股票推薦</li>
</ul>
</div><p>Several other institutional investors have also recently made changes to their positions in FMS. Bank of America Corp DE increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 279.7% in the second quarter. Bank of America Corp DE now owns 337,316 shares of the company's stock worth $9,637,000 after purchasing an additional 248,477 shares during the period. ABC Arbitrage SA increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 1,136.0% in the fourth quarter. ABC Arbitrage SA now owns 249,800 shares of the company's stock worth $5,950,000 after purchasing an additional 229,589 shares during the period. Pzena Investment Management LLC increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 1.0% in the third quarter. Pzena Investment Management LLC now owns 14,816,852 shares of the company's stock worth $390,128,000 after purchasing an additional 153,870 shares during the period. Qube Research &amp; Technologies Ltd increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 175.3% in the second quarter. Qube Research &amp; Technologies Ltd now owns 199,563 shares of the company's stock worth $5,702,000 after purchasing an additional 127,073 shares during the period. Finally, Moran Wealth Management LLC increased its holdings in shares of Fresenius Medical Care AG &amp; Co. KGaA by 67.4% in the fourth quarter. Moran Wealth Management LLC now owns 264,462 shares of the company's stock worth $6,299,000 after purchasing an additional 106,438 shares during the period. Institutional investors own 8.37% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家機構投資者最近也對 FMS 的持倉進行了調整。美國銀行公司 DE 在第二季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 279.7%。美國銀行公司 DE 目前持有 337,316 股該公司的股票，價值 9,637,000 美元，此前在此期間又購買了 248,477 股。ABC Arbitrage SA 在第四季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1,136.0%。ABC Arbitrage SA 目前持有 249,800 股該公司的股票，價值 5,950,000 美元，此前在此期間又購買了 229,589 股。Pzena Investment Management LLC 在第三季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 1.0%。Pzena Investment Management LLC 目前持有 14,816,852 股該公司的股票，價值 390,128,000 美元，此前在此期間又購買了 153,870 股。Qube Research &amp; Technologies Ltd 在第二季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 175.3%。Qube Research &amp; Technologies Ltd 目前持有 199,563 股該公司的股票，價值 5,702,000 美元，此前在此期間又購買了 127,073 股。最後，Moran Wealth Management LLC 在第四季度將其在 Fresenius Medical Care AG &amp; Co. KGaA 的持股增加了 67.4%。Moran Wealth Management LLC 目前持有 264,462 股該公司的股票，價值 6,299,000 美元，此前在此期間又購買了 106,438 股。機構投資者目前持有該公司 8.37% 的股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several research analysts have recently weighed in on FMS shares. Zacks Research cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a report on Wednesday, May 27th. Wall Street Zen cut shares of Fresenius Medical Care AG &amp; Co. KGaA from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, May 9th. Weiss Ratings cut Fresenius Medical Care AG &amp; Co. KGaA from a &#34;hold (c+)&#34; rating to a &#34;hold (c)&#34; rating in a research note on Thursday, May 7th. Citigroup reissued a &#34;neutral&#34; rating on shares of Fresenius Medical Care AG &amp; Co. KGaA in a research note on Friday, April 24th. Finally, Morgan Stanley reissued an &#34;underweight&#34; rating on shares of Fresenius Medical Care AG &amp; Co. KGaA in a research note on Wednesday, May 6th. Four analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of &#34;Strong Sell&#34; and a consensus price target of $28.00.</p>
<div class="lb-trans"><p>幾位研究分析師最近對 FMS 股票發表了看法。Zacks Research 在 5 月 27 日的報告中將 Fresenius Medical Care AG &amp; Co. KGaA 的股票評級從 &#34;持有&#34; 下調至 &#34;強烈賣出&#34;。Wall Street Zen 在 5 月 9 日的報告中將 Fresenius Medical Care AG &amp; Co. KGaA 的股票評級從 &#34;買入&#34; 下調至 &#34;持有&#34;。Weiss Ratings 在 5 月 7 日的研究報告中將 Fresenius Medical Care AG &amp; Co. KGaA 的評級從 &#34;持有 (c+)&#34; 下調至 &#34;持有 (c)&#34;。花旗集團在 4 月 24 日的研究報告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;中性&#34; 評級。最後，摩根士丹利在 5 月 6 日的研究報告中重申了 Fresenius Medical Care AG &amp; Co. KGaA 的 &#34;減持&#34; 評級。四位分析師對該股票給予了持有評級，五位分析師對該公司的股票給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 &#34;強烈賣出&#34;，共識目標價為 28.00 美元。</p>
</div><ul>
<li>Best Healthcare Stocks - Healthcare Stocks to Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>最佳醫療保健股票 - 現在值得購買的醫療保健股票</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on Fresenius Medical Care AG &amp; Co. KGaA</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 Fresenius Medical Care AG &amp; Co. KGaA 的最新股票報告</strong></p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Stock Up 0.4%</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG &amp; Co. KGaA 股票上漲 0.4%</h2>
</div><p>FMS opened at $22.03 on Friday. The stock has a market cap of $11.90 billion, a PE ratio of 11.59, a P/E/G ratio of 3.97 and a beta of 0.80. The company has a quick ratio of 0.86, a current ratio of 1.20 and a debt-to-equity ratio of 0.40. Fresenius Medical Care AG &amp; Co. KGaA has a 52 week low of $20.02 and a 52 week high of $29.07. The business's fifty day simple moving average is $22.23 and its 200 day simple moving average is $22.87.</p>
<div class="lb-trans"><p>FMS 週五開盤價為 22.03 美元。該股票的市值為 119 億美元，市盈率為 11.59，市盈率/增長比率為 3.97，貝塔值為 0.80。該公司的速動比率為 0.86，流動比率為 1.20，債務與股本比率為 0.40。Fresenius Medical Care AG &amp; Co. KGaA 的 52 周低點為 20.02 美元，52 周高點為 29.07 美元。該公司的 50 日簡單移動平均線為 22.23 美元，200 日簡單移動平均線為 22.87 美元。</p>
</div><p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - Get Free Report) last released its earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. The business had revenue of $5.34 billion for the quarter. Fresenius Medical Care AG &amp; Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%. As a group, research analysts expect that Fresenius Medical Care AG &amp; Co. KGaA will post 2.24 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG &amp; Co. KGaA (NYSE:FMS - 獲取免費報告) 最近於 3 月 31 日發佈了其財報。該公司報告季度每股收益為 1.05 美元。該業務的季度收入為 53.4 億美元。Fresenius Medical Care AG &amp; Co. KGaA 的股本回報率為 8.90%，淨利潤率為 4.88%。作為一個整體，研究分析師預計 Fresenius Medical Care AG &amp; Co. KGaA 在當前財政年度將發佈 2.24 美元的每股收益。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Increases Dividend</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG &amp; Co. KGaA 增加股息</h2>
</div><p>The company also recently announced an annual dividend, which will be paid on Monday, June 8th. Investors of record on Friday, May 22nd will be paid a $0.8716 dividend. This is a boost from Fresenius Medical Care AG &amp; Co. KGaA's previous annual dividend of $0.79. This represents a yield of 402.0%. The ex-dividend date of this dividend is Friday, May 22nd. Fresenius Medical Care AG &amp; Co. KGaA's payout ratio is currently 32.11%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項年度股息，將於 6 月 8 日支付。5 月 22 日的登記投資者將獲得 0.8716 美元的股息。這比 Fresenius Medical Care AG &amp; Co. KGaA 之前的年度股息 0.79 美元有所增加。這代表了 402.0% 的收益率。該股息的除息日期為 5 月 22 日。Fresenius Medical Care AG &amp; Co. KGaA 目前的派息比率為 32.11%。</p>
</div><h2>Fresenius Medical Care AG &amp; Co. KGaA Company Profile</h2>
<div class="lb-trans"><h2>Fresenius Medical Care AG &amp; Co. KGaA 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Fresenius Medical Care AG &amp; Co KGaA is the world's largest integrated provider of products and services for individuals with renal diseases. The company's primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG &amp; Co KGaA 是全球最大的腎臟疾病產品和服務的綜合供應商。該公司的主要業務活動包括運營透析診所以及製造和分銷透析設備、透析機、透析器、耗材和相關療法。通過其全球診所網絡，Fresenius Medical Care 提供全面的腎臟護理，包括血液透析和腹膜透析治療、患者教育和支持服務。</p>
</div><p>In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.</p>
<div class="lb-trans"><p>在其產品部門，該公司設計和生產透析機、水處理系統以及高通量透析器和血管通路等一次性耗材。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?</li>
<li>IREN's 800MW Bet Flips the AI Power Switch</li>
<li>CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?</li>
<li>Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Fresenius Medical Care AG &amp; Co. KGaA</li>
<li>Samsara 剛剛回答了 AI 問題——華爾街準備好傾聽了嗎？</li>
<li>IREN 的 800MW 投資開啓了 AI 電力開關</li>
<li>CrowdStrike 財報超預期引發拋售——是否值得買入？</li>
<li>特斯拉的電動車反彈讓 Rivian 和 Lucid 面臨更嚴峻的投資者考驗</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZNUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=FMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Fresenius Medical Care AG &amp; Co. KGaA Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Fresenius Medical Care AG &amp; Co. KGaA 嗎？</h2>
</div><p>Before you consider Fresenius Medical Care AG &amp; Co. KGaA, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Fresenius Medical Care AG &amp; Co. KGaA 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care AG &amp; Co. KGaA wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Fresenius Medical Care AG &amp; Co. KGaA 並不在名單上。</p>
</div><p>While Fresenius Medical Care AG &amp; Co. KGaA currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Fresenius Medical Care AG &amp; Co. KGaA 目前在分析師中被評為強烈賣出，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Fiduciary Management Inc. WI Sells 495,419 Shares of Fresenius Medical Care AG & Co. KGaA $FMS

Market Beat

Fresenius Medical Care

美國銀行

花旗

摩根士丹利

Fresenius Medical Care AG & Co. KGaA

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

CITIGROUP INC 6.250 NON CUM SER II PFD WI

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Fiduciary Management Inc. WI 出售了 495,419 股 Fresenius Medical Care AG & Co. KGaA 的股票，股票代碼為 $FMS